BusinessOTraces’ TME Cancer Blood Test Presentation at Innovation Challenge Spurs Investor Interest from JP Morgan Healthcare Conference ParticipantsBy Nasdaq OMXJan 11, 2018, 6:39 PM UTC
BusinessExosome Diagnostics Places Early Access Shahky™ Exosomal Protein Detection System at MGH Center for Systems BiologyBy Nasdaq OMXJan 9, 2018, 12:46 PM UTC
BusinessExosome Diagnostics Announces Positive Coverage for EPI from Largest Payor in the Mid-Atlantic RegionBy Nasdaq OMXJan 8, 2018, 6:15 PM UTC
BusinessExosome Diagnostics Places Its First Early Access Shahky System within a Top 15 Pharmaceutical LaboratoryBy Nasdaq OMXJan 8, 2018, 12:56 PM UTC
BusinessExosome Diagnostics Launches National Sales Team to Support Flagship Test, ExoDx®Prostate(IntelliScore)By Nasdaq OMXJan 3, 2018, 12:31 PM UTC
BusinessExosome Diagnostics Publishes a Study Demonstrating Superior Performance of ExoLution™ Plus Liquid Biopsy Platform in Lung CancerBy Nasdaq OMXDec 19, 2017, 12:51 PM UTC
BusinessBiodesix Leaders Share Commercial and Pipeline Updates at Annual qPCR and dPCR CongressBy Nasdaq OMXDec 5, 2017, 11:00 AM UTC
BusinessExosome Diagnostics Announces National Medicare Reimbursement Rate Set at $760 for its Prostate Cancer IntelliScore TestBy Nasdaq OMXNov 27, 2017, 1:16 PM UTC
